Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria.

Macintyre F, Ramachandruni H, Burrows JN, Holm R, Thomas A, Möhrle JJ, Duparc S, Hooft van Huijsduijnen R, Greenwood B, Gutteridge WE, Wells TNC, Kaszubska W.

Malar J. 2018 Nov 1;17(1):402. doi: 10.1186/s12936-018-2549-1. Review.

2.

Erratum to: New developments in anti-malarial target candidate and product profiles.

Burrows JN, Duparc S, Gutteridge WE, van Huijsduijnen RH, Kaszubska W, Macintyre F, Mazzuri S, Möhrle JJ, Wells TNC.

Malar J. 2017 Apr 18;16(1):151. doi: 10.1186/s12936-017-1809-9. No abstract available.

3.

New developments in anti-malarial target candidate and product profiles.

Burrows JN, Duparc S, Gutteridge WE, Hooft van Huijsduijnen R, Kaszubska W, Macintyre F, Mazzuri S, Möhrle JJ, Wells TNC.

Malar J. 2017 Jan 13;16(1):26. doi: 10.1186/s12936-016-1675-x. Review. Erratum in: Malar J. 2017 Apr 18;16(1):151.

4.

Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C.

Falls HD, Dayton BD, Fry DG, Ogiela CA, Schaefer VG, Brodjian S, Reilly RM, Collins CA, Kaszubska W.

J Mol Endocrinol. 2006 Aug;37(1):51-62.

PMID:
16901923
5.

2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.

Serby MD, Zhao H, Szczepankiewicz BG, Kosogof C, Xin Z, Liu B, Liu M, Nelson LT, Kaszubska W, Falls HD, Schaefer V, Bush EN, Shapiro R, Droz BA, Knourek-Segel VE, Fey TA, Brune ME, Beno DW, Turner TM, Collins CA, Jacobson PB, Sham HL, Liu G.

J Med Chem. 2006 Apr 20;49(8):2568-78.

PMID:
16610800
6.

Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain exploration.

Liu B, Liu M, Xin Z, Zhao H, Serby MD, Kosogof C, Nelson LT, Szczepankiewicz BG, Kaszubska W, Schaefer VG, Falls HD, Lin CW, Collins CA, Sham HL, Liu G.

Bioorg Med Chem Lett. 2006 Apr 1;16(7):1864-8. Epub 2006 Jan 25.

PMID:
16442284
7.

Structure-activity relationship studies on tetralin carboxamide growth hormone secretagogue receptor antagonists.

Zhao H, Xin Z, Patel JR, Nelson LT, Liu B, Szczepankiewicz BG, Schaefer VG, Falls HD, Kaszubska W, Collins CA, Sham HL, Liu G.

Bioorg Med Chem Lett. 2005 Apr 1;15(7):1825-8.

PMID:
15780615
8.

Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.

Xin Z, Zhao H, Serby MD, Liu B, Schaefer VG, Falls DH, Kaszubska W, Colins CA, Sham HL, Liu G.

Bioorg Med Chem Lett. 2005 Feb 15;15(4):1201-4.

PMID:
15686942
9.

Discovery of tetralin carboxamide growth hormone secretagogue receptor antagonists via scaffold manipulation.

Zhao H, Xin Z, Liu G, Schaefer VG, Falls HD, Kaszubska W, Collins CA, Sham HL.

J Med Chem. 2004 Dec 30;47(27):6655-7.

PMID:
15615511
10.

Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors.

Zhao H, Liu G, Xin Z, Serby MD, Pei Z, Szczepankiewicz BG, Hajduk PJ, Abad-Zapatero C, Hutchins CW, Lubben TH, Ballaron SJ, Haasch DL, Kaszubska W, Rondinone CM, Trevillyan JM, Jirousek MR.

Bioorg Med Chem Lett. 2004 Nov 15;14(22):5543-6.

PMID:
15482920
11.

Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.

Liu B, Liu G, Xin Z, Serby MD, Zhao H, Schaefer VG, Falls HD, Kaszubska W, Collins CA, Sham HL.

Bioorg Med Chem Lett. 2004 Oct 18;14(20):5223-6.

PMID:
15380232
12.

Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.

Liu G, Xin Z, Pei Z, Hajduk PJ, Abad-Zapatero C, Hutchins CW, Zhao H, Lubben TH, Ballaron SJ, Haasch DL, Kaszubska W, Rondinone CM, Trevillyan JM, Jirousek MR.

J Med Chem. 2003 Sep 25;46(20):4232-5.

PMID:
13678400
13.

Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line.

Kaszubska W, Falls HD, Schaefer VG, Haasch D, Frost L, Hessler P, Kroeger PE, White DW, Jirousek MR, Trevillyan JM.

Mol Cell Endocrinol. 2002 Sep 30;195(1-2):109-18.

PMID:
12354677
14.

Expression, purification, and characterization of human recombinant thrombopoietin in Chinese hamster ovary cells.

Kaszubska W, Zhang H, Patterson RL, Suhar TS, Uchic ME, Dickinson RW, Schaefer VG, Haasch D, Janis RS, DeVries PJ, Okasinski GF, Meuth JL.

Protein Expr Purif. 2000 Mar;18(2):213-20.

PMID:
10686152
16.

ATF-a0, a novel variant of the ATF/CREB transcription factor family, forms a dominant transcription inhibitor in ATF-a heterodimers.

Pescini R, Kaszubska W, Whelan J, DeLamarter JF, Hooft van Huijsduijnen R.

J Biol Chem. 1994 Jan 14;269(2):1159-65.

17.

Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines.

Kaszubska W, Hooft van Huijsduijnen R, Ghersa P, DeRaemy-Schenk AM, Chen BP, Hai T, DeLamarter JF, Whelan J.

Mol Cell Biol. 1993 Nov;13(11):7180-90.

18.

Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B.

Matthews JR, Kaszubska W, Turcatti G, Wells TN, Hay RT.

Nucleic Acids Res. 1993 Apr 25;21(8):1727-34.

19.

Purification and characterization of the M.RsrI DNA methyltransferase from Escherichia coli.

Kaszubska W, Webb HK, Gumport RI.

Gene. 1992 Sep 1;118(1):5-11.

PMID:
1511884
21.

RsrI restriction-modification enzymes from Rhodobacter sphaeroides.

Kaszubska W, Aiken CR, Gumport RI.

Gene. 1988 Dec 25;74(1):83-4. No abstract available.

PMID:
3266862

Supplemental Content

Loading ...
Support Center